Trojano: “Ofatumumab changes the way of treating multiple sclerosis”

Maria Trojano, full professor of Neurology at the “Aldo Moro” University of Bari, explains the characteristics of Ofatumumab, the first highly effective home treatment targeted at B cells indicated for adults with relapsing remitting multiple sclerosis in which the patient has exacerbations followed by periods with milder or no symptoms.